Pal nasal spray
Latest Information Update: 25 Aug 2006
At a glance
- Originator Rockefeller University
- Mechanism of Action Cell membrane modulators
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- No development reported Streptococcal infections
Most Recent Events
- 25 Aug 2006 No development reported - Preclinical for Streptococcal infections in USA (Intranasal)
- 08 Feb 2002 Preclinical development for Streptococcal infections in USA (Intranasal)